Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia

Alexandra I Ershova1, Alexey N Meshkov1, Tatyana A Rozhkova2

  • 1Department of clinical cardiology and molecular genetics, National Research Center for Preventive Medicine, Moscow, Russia.

Plos One
|July 20, 2016
PubMed

Insights

Patients with familial hypercholesterolemia (FH) exhibit stiffer carotid arteries but not aortic stiffness compared to relatives. Arterial elasticity reduces earlier in the carotid arteries than the aorta in FH patients.

Area of Science:

  • Cardiovascular Medicine
  • Arterial Physiology
  • Lipid Metabolism Disorders

Background:

  • The impact of high plasma cholesterol on arterial health is not fully understood.
  • Familial hypercholesterolemia (FH) presents an opportunity to study cholesterol's effects on arterial function.
  • Arterial stiffness is a key indicator of cardiovascular health.

Purpose of the Study:

  • To evaluate arterial stiffness in treatment-naive patients with heterozygous FH.
  • To compare local carotid artery stiffness and aortic stiffness between FH patients and their relatives.
  • To investigate the age-related changes in arterial elasticity in FH.

Main Methods:

  • Utilized high-resolution echo-tracking for local common carotid artery stiffness assessment.
  • Measured aortic stiffness using carotid-femoral pulse wave velocity (PWV).
  • Included 66 FH patients and 57 non-FH relatives, assessing carotid stiffness parameters (β-index, Peterson elastic modulus, local PWV).

Main Results:

  • FH patients demonstrated significantly higher carotid artery stiffness (β-index, Ep, local PWV).
  • No significant difference in aortic stiffness (carotid-femoral PWV) was observed between FH patients and controls.
  • Carotid arteries and aorta stiffened with age in FH patients, with more pronounced carotid stiffening after age 30.

Conclusions:

  • Treatment-naive FH patients exhibit increased carotid artery stiffness compared to relatives.
  • Aortic stiffness does not differ between FH patients and their relatives.
  • The decline in arterial elasticity occurs earlier in the carotid arteries than in the aorta in individuals with FH.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
707
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
894
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
553
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K